CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc. financial statements

CNS Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 15.85M10-K
Cash and equivalentsUSD 7.2M10-Q
Total debtUSD 328.57KEODHD

CNS Pharmaceuticals, Inc. financials on 6ix · CNS Pharmaceuticals, Inc. on 6ix